| |
| |
|
| Insider
Information: |
Claiborne Cary J |
| Relationship: |
Chief Executive Office... |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
2,033,560 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,783,730 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,033,560 |
|
|
| Total
Value |
$1,783,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Osiris Therapeutics, Inc. |
OSIR |
Chief Financial Officer |
2007-03-02 |
75,000 |
|
0 |
Premium* |
|
|
New Generation Biofuels Holdings... |
NGBF |
former CEO, CFO & Pres... |
2010-03-06 |
435,696 |
2008-01-10 |
0 |
Premium* |
|
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Former Chief Financial... |
2014-12-16 |
2,864 |
2012-03-30 |
0 |
Premium* |
|
|
Adial Pharmaceuticals, Inc. |
ADIL |
Chief Executive Office... |
2023-05-23 |
1,520,000 |
2022-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
420,000 |
1,520,000 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2022-09-20 |
4 |
A |
$0.42 |
$31,515 |
D/D |
75,000 |
1,100,000 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2022-09-19 |
4 |
A |
$0.43 |
$10,735 |
D/D |
25,000 |
1,025,000 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• – – |
2022-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Former Chief Financial Officer |
– – – |
2014-12-16 |
4 |
OE |
$4.07 |
$174,603 |
D/D |
42,900 |
45,764 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Former Chief Financial Officer |
– – – |
2014-12-16 |
4 |
S |
$12.91 |
$553,839 |
D/D |
(42,900) |
2,864 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Former Chief Financial Officer |
– – – |
2014-12-15 |
4 |
S |
$12.89 |
$91,519 |
D/D |
(7,100) |
2,864 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Former Chief Financial Officer |
– – – |
2014-12-15 |
4 |
OE |
$4.07 |
$28,897 |
D/D |
7,100 |
9,964 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-06-30 |
4 |
A |
$6.56 |
$1,752 |
D/D |
267 |
2,621 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-03-31 |
4 |
A |
$6.79 |
$1,494 |
D/D |
220 |
2,354 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-02-27 |
4 |
OE |
$4.07 |
$10,175 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-02-27 |
4 |
AS |
$9.00 |
$22,507 |
D/D |
(2,500) |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
AS |
$9.00 |
$22,500 |
D/D |
(2,500) |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2014-01-07 |
4 |
OE |
$4.07 |
$10,991 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2013-12-31 |
4 |
A |
$8.93 |
$1,750 |
D/D |
196 |
2,134 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-11-25 |
4 |
OE |
$7.64 |
$99,236 |
D/D |
12,989 |
109,898 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-11-22 |
4 |
OE |
$7.46 |
$26,192 |
D/D |
3,511 |
122,887 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-09-30 |
4 |
A |
$5.93 |
$1,500 |
D/D |
253 |
1,938 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-06-28 |
4/A |
A |
$6.25 |
$1,750 |
D/D |
280 |
1,685 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-05-24 |
4 |
OE |
$9.00 |
$92,735 |
D/D |
10,300 |
125,865 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2013-05-21 |
4 |
S |
$9.55 |
$22,914 |
D/D |
(2,400) |
136,165 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2013-05-20 |
4 |
S |
$9.50 |
$21,280 |
D/D |
(2,240) |
138,565 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief financial officer |
• – – |
2013-03-28 |
4 |
A |
$6.21 |
$1,504 |
D/D |
242 |
1,405 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2012-12-31 |
4 |
A |
$4.66 |
$1,750 |
D/D |
376 |
1,163 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2012-09-28 |
4 |
A |
$4.78 |
$1,496 |
D/D |
313 |
787 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
